APA (7th ed.) Citation

D, C., C, M., F, S., LS, K., S, L., P, G., . . . CP, M. (2025). Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Molecular psychiatry, 30(7), 2891. https://doi.org/10.1038/s41380-025-02893-6

Chicago Style (17th ed.) Citation

D, Chestnykh, et al. "Acid Sphingomyelinase Activity Suggests a New Antipsychotic Pharmaco-treatment Strategy for Schizophrenia." Molecular Psychiatry 30, no. 7 (2025): 2891. https://doi.org/10.1038/s41380-025-02893-6.

MLA (9th ed.) Citation

D, Chestnykh, et al. "Acid Sphingomyelinase Activity Suggests a New Antipsychotic Pharmaco-treatment Strategy for Schizophrenia." Molecular Psychiatry, vol. 30, no. 7, 2025, p. 2891, https://doi.org/10.1038/s41380-025-02893-6.